1YRSXi 'an Ruicheng Medical Technology Co., Ltd.

COMPANY OVERVIEW

Company Album3

Basic Information
The company is dedicated to the development and research of new fluorine-containing aromatic heterocyclic compounds, especially experienced in the synthesis of fluoropyridine, pyrazine, pyrimidine, thiophene, thiazole and other heterocyclic compounds.
  • Transactions
    -
  • Response Time
    ≤4h
  • Response rate
    96.55%
Business type
Trading Company
Country / Region
Shaanxi, China
Main ProductsTotal employees
11 - 50 People
Total Annual Revenue
US$1 Million - US$2.5 Million
Year established
2023
Certifications
-
Product Certifications
-
Patents
-
Trademarks
-
Main Markets

R&D CAPACITY

Research & Development

11 - 20 People

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets
Total Revenue(%)
Main Product(s)
Verified
Central America
50.00%
Domestic Market
20.00%
Southeast Asia
10.00%
Southern Europe
10.00%
Western Europe
10.00%
Verified

Trade Ability

Language Spoken
English, Chinese
No. of Employees in Trade Department
1-2 People
Total Annual Revenue
US$1 Million - US$2.5 Million

Business Terms

Accepted Delivery Terms
FOB
Accepted Payment Currency
USD, CNY